WallStreetZenWallStreetZen

NASDAQ: ZJYL
Jin Medical International Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

ZJYL past earnings growth

How has ZJYL's earnings growth performed historically?
Company
0%
Industry
27.29%
Market
99.73%
ZJYL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ZJYL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

ZJYL past revenue growth

How has ZJYL's revenue growth performed historically?
Company
3.29%
Industry
7.52%
Market
17.8%
ZJYL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZJYL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZJYL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZJYL earnings and revenue history

Current Revenue
$19.8M
Current Earnings
$2.9M
Current Profit Margin
14.5%

ZJYL Return on Equity

Current Company
14.7%
Current Industry
10.8%
Current Market
-9.4%
ZJYL's Return on Equity (14.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZJYL announces earnings.

ZJYL Return on Assets

Current Company
10.7%
Current Industry
6.7%
ZJYL is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZJYL Return on Capital Employed

Current Company
12.67%
Current Industry
9.6%

ZJYL vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZJYL$19.82M$3.27M$2.88M-2.30%0.00%
EMBC$1.12B$207.60M$55.30M-2.03%-63.46%
PLSE$0.00-$42.37M-$42.21M-100.00%N/A
ATRI$169.33M$37.62M$19.41M+2.12%-9.83%
OSUR$405.47M$77.19M$53.66M+17.41%+17.21%
View Top Medical Stocks

Jin Medical International Earnings & Revenue FAQ

What were ZJYL's earnings last quarter?

Jin Medical International (NASDAQ: ZJYL) reported Q3 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Jin Medical International earnings for the quarter were N/A. In the same quarter last year, Jin Medical International's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Jin Medical International stock.

What was ZJYL's earnings growth in the past year?

As of Q2 2024, Jin Medical International's earnings has grown 0% year over year. This is 27.29 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 27.29%. Jin Medical International's earnings in the past year totalled $2.88 million.

What was ZJYL's revenue last quarter?

Jin Medical International (NASDAQ: ZJYL) reported Q3 2023 revenue of N/A up N/A year over year. In the same quarter last year, Jin Medical International's revenue was N/A.

What was ZJYL's revenue growth in the past year?

As of Q2 2024, Jin Medical International's revenue has grown 3.29% year over year. This is 4.23 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.52%. Jin Medical International's revenue in the past year totalled $19.82 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.